We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and diagnostic imaging equipment and other contrast agents, including computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRiseTM and digital prediction systems that integrate data from farm equipment, satellites, field sensors, irrigation systems, drones, and other input sources and then analyze that data to allow farmers to make decisions through data science and predictive analytics. The company also exports its products. Bayer CropScience Limited was incorporated in 1958 and is based in Thane, India.
TODAY'S HIGH
4824
TODAY'S LOW
4702.6
52 WEEK HIGH
5667.75
52 WEEK LOW
4218.05
% of Shares Held by
All Insider
72.72%
% of Shares Held by
Institutions
13.01%
% of Float Held by
Institutions
47.71%
Number of Institutions
Holding Shares
53
MARKET CAP
21383.28 Cr.
ETERPRISE VALUE
20948.07 Cr.
NO. OF SHARES
4.49 Cr.
BOOK VALUE
640.537
DIV. YIELD
100%
DEBT
83.10 Cr.
GROSS PROFIT
2057.30 Cr.
CASH
620.19 Cr.
REVENUE
5072.69 Cr.
REVENUE/SHARE
1128.708
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 23.10 Cr. | -1.10 Cr. | -40 Cr. | -396 Cr. |
| Change To Liabilities | -9.70 Cr. | 355.80 Cr. | -169.10 Cr. | 250.30 Cr. |
| Total cashflows from Investing Activities | 64.20 Cr. | 6.70 Cr. | -28.90 Cr. | -414.70 Cr. |
| Net Borrowings | -26.30 Cr. | -37 Cr. | -22.80 Cr. | -22.80 Cr. |
| Total Cash from Financing Activities | -703.30 Cr. | -555.80 Cr. | -148.30 Cr. | -158.30 Cr. |
| Other Liabilities | 96.20 Cr. | 70.20 Cr. | 53.30 Cr. | -43.10 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 645.30 Cr. | 493.10 Cr. | 474.50 Cr. | 337.10 Cr. |
| Change in Cash | -423.60 Cr. | 137.60 Cr. | 488.70 Cr. | -140.20 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 215.50 Cr. | 686.70 Cr. | 665.90 Cr. | 432.80 Cr. |
| Depreciation | 64.50 Cr. | 73 Cr. | 63.70 Cr. | 41.20 Cr. |
| Other Cashflows from Investing Activities | 27 Cr. | 39 Cr. | 39 Cr. | 35.80 Cr. |
| Dividends Paid | -672.80 Cr. | -516 Cr. | -101.50 Cr. | -126.10 Cr. |
| Change to Inventory | -236.40 Cr. | -395.60 Cr. | 164.40 Cr. | -288.70 Cr. |
| Change to Account Receivables | -256.30 Cr. | -37.80 Cr. | -20.50 Cr. | 171.70 Cr. |
| Other Cashflows from Financing Activities | -4.20 Cr. | -2.80 Cr. | -24 Cr. | -32.20 Cr. |
| Change to Net Income | -88.10 Cr. | 127.50 Cr. | 98 Cr. | -38.30 Cr. |
| Capital Expenditures | -55.40 Cr. | -42 Cr. | -41.30 Cr. | -60.20 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 846.80 Cr. | 794.50 Cr. | 583.10 Cr. | 480 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 746.60 Cr. | 738.50 Cr. | 662.20 Cr. | 469.10 Cr. |
| Selling General Administrative | 463.10 Cr. | 572.60 Cr. | 572.90 Cr. | 601 Cr. |
| Gross Profit | 2070.20 Cr. | 1799.40 Cr. | 1682.90 Cr. | 1497.50 Cr. |
| Ebit | 746.60 Cr. | 738.50 Cr. | 662.20 Cr. | 469.10 Cr. |
| Operating Income | 746.60 Cr. | 738.50 Cr. | 662.20 Cr. | 469.10 Cr. |
| Other Operating Expenses | 796 Cr. | 414.80 Cr. | 382.50 Cr. | 383.60 Cr. |
| Interest Expense | -12.90 Cr. | -11 Cr. | -12.60 Cr. | -9.80 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 201.50 Cr. | 301.40 Cr. | 108.60 Cr. | 142.90 Cr. |
| Total Revenue | 4734.40 Cr. | 4261.30 Cr. | 3609.40 Cr. | 3175.40 Cr. |
| Total Operating Expenses | 3987.80 Cr. | 3522.80 Cr. | 2947.20 Cr. | 2706.30 Cr. |
| Cost of Revenue | 2664.20 Cr. | 2461.90 Cr. | 1926.50 Cr. | 1677.90 Cr. |
| Total Other Income Expense Net | 100.20 Cr. | 56 Cr. | -79.10 Cr. | 10.90 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 645.30 Cr. | 493.10 Cr. | 474.50 Cr. | 337.10 Cr. |
| Net Income Applicable to Common Shares | 645.30 Cr. | 493.10 Cr. | 474.50 Cr. | 337.10 Cr. |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 89.30 Cr. | 70.20 Cr. | 54 Cr. | 42.60 Cr. |
| Capital Surplus | 0 | 139.40 Cr. | 139.40 Cr. | 139.40 Cr. |
| Total Liabilities | 1828.60 Cr. | 1689 Cr. | 1263.20 Cr. | 1309.80 Cr. |
| Stock Holder Equity | 2524.30 Cr. | 2550.30 Cr. | 2572.50 Cr. | 2239.40 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 804.90 Cr. | 644.60 Cr. | 526.10 Cr. | 453.60 Cr. |
| Total Assets | 4352.90 Cr. | 4239.30 Cr. | 3835.70 Cr. | 3549.20 Cr. |
| Common Stock | 44.90 Cr. | 44.90 Cr. | 44.90 Cr. | 34.30 Cr. |
| Retained Earnings | 0 | 2360.80 Cr. | 2383 Cr. | 2049.90 Cr. |
| Other Liabilities | 117.50 Cr. | 104.30 Cr. | 110 Cr. | 121.90 Cr. |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 2479.40 Cr. | 5.20 Cr. | 5.20 Cr. | 15.80 Cr. |
| Other Assets | 237.70 Cr. | 224.40 Cr. | 327.40 Cr. | 312.90 Cr. |
| Cash | 787.40 Cr. | 1204.50 Cr. | 1066.90 Cr. | 578.20 Cr. |
| Current Liabilities | 1659.30 Cr. | 1570.60 Cr. | 1139.40 Cr. | 1187.90 Cr. |
| Long Term Asset Charges | 7.30 Cr. | 17.90 Cr. | 27 Cr. | 8.90 Cr. |
| Short Long Term Debt | 0 | 0 | 0 | 0 |
| Other Stockholder Equity | 2479.40 Cr. | 5.20 Cr. | 5.20 Cr. | 15.80 Cr. |
| Property Plant Equipment | 450.40 Cr. | 400.80 Cr. | 439.90 Cr. | 413.90 Cr. |
| Total Cur. Assets | 3575.50 Cr. | 3543.90 Cr. | 3014.40 Cr. | 2779.80 Cr. |
| Long Term Investments | 0 | 0 | 0 | 0 |
| Net Tangible Assets | 2435 Cr. | 2480.10 Cr. | 2518.50 Cr. | 2196.80 Cr. |
| Short Term Investments | 38.50 Cr. | 0 | 0 | 0 |
| Net Receivables | 1004.70 Cr. | 763.80 Cr. | 740.40 Cr. | 755.90 Cr. |
| Long Term Debt | 0 | 0 | 0 | 0 |
| Inventory | 1512 Cr. | 1325.10 Cr. | 963.50 Cr. | 1157 Cr. |
| Accounts Payable | 819.80 Cr. | 830.30 Cr. | 474.90 Cr. | 644.20 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account